|Guidelines for the treatment of malaria|
World Health Organization
World Health Organization, 2015
|Epidemiology of dengue: past, present and future prospects|
NEA Murray, MB Quam, A Wilder-Smith
Clinical epidemiology 5, 299, 2013
|Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants|
M Kosek, R Haque, A Lima, S Babji, S Shrestha, S Qureshi, S Amidou, ...
The American journal of tropical medicine and hygiene 88 (2), 390-396, 2013
|Dengue in travelers|
A Wilder-Smith, E Schwartz
New England journal of medicine 353 (9), 924-932, 2005
|The reproductive number of COVID-19 is higher compared to SARS coronavirus|
Y Liu, AA Gayle, A Wilder-Smith, J Rocklöv
Journal of travel medicine, 2020
|Geographic expansion of dengue: the impact of international travel|
A Wilder-Smith, DJ Gubler
Medical Clinics of North America 92 (6), 1377-1390, 2008
|Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network|
CD Ericsson, C Hatz, K Leder, S Tong, L Weld, KC Kain, A Wilder-Smith, ...
Clinical Infectious Diseases 43 (9), 1185-1193, 2006
|GeoSentinel surveillance of illness in returned travelers, 2007–2011|
K Leder, J Torresi, MD Libman, JP Cramer, F Castelli, P Schlagenhauf, ...
Annals of internal medicine 158 (6), 456-468, 2013
|Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination|
WH Van Brakel, B Sihombing, H Djarir, K Beise, L Kusumawardhani, ...
Global health action 5 (1), 18394, 2012
|Vectorial capacity of Aedes aegypti: effects of temperature and implications for global dengue epidemic potential|
J Liu-Helmersson, H Stenlund, A Wilder-Smith, J Rocklöv
PloS one 9 (3), 2014
|Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak|
A Wilder-Smith, DO Freedman
Journal of travel medicine 27 (2), taaa020, 2020
|Epidemic arboviral diseases: priorities for research and public health|
A Wilder-Smith, DJ Gubler, SC Weaver, TP Monath, DL Heymann, ...
The Lancet infectious diseases 17 (3), e101-e106, 2017
|Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997–2006|
E Schwartz, LH Weld, A Wilder-Smith, F von Sonnenburg, JS Keystone, ...
Emerging infectious diseases 14 (7), 1081, 2008
|The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever|
ES Jentes, G Poumerol, MD Gershman, DR Hill, J Lemarchand, RF Lewis, ...
The Lancet infectious diseases 11 (8), 622-632, 2011
|Travel health knowledge, attitudes and practices among Australasian travelers|
A Wilder-Smith, NS Khairullah, JH Song, CY Chen, J Torresi
Journal of Travel Medicine 11 (1), 9-15, 2004
|Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development|
A Wilder-Smith, EE Ooi, SG Vasudevan, DJ Gubler
Current infectious disease reports 12 (3), 157-164, 2010
|Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis|
D Chadwick, B Arch, A Wilder-Smith, N Paton
Journal of Clinical Virology 35 (2), 147-153, 2006
|Threat of dengue to blood safety in dengue-endemic countries|
A Wilder-Smith, LH Chen, E Massad, ME Wilson
Emerging infectious diseases 15 (1), 8, 2009
|Can we contain the COVID-19 outbreak with the same measures as for SARS?|
A Wilder-Smith, CJ Chiew, VJ Lee
The Lancet Infectious Diseases, 2020
|Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network|
AK Boggild, F Castelli, P Gautret, J Torresi, F von Sonnenburg, ED Barnett, ...
Vaccine 28 (46), 7389-7395, 2010